儿童拔管失败的危险因素:呼吸肌力量的重要性
该研究为前瞻性收集数据的二次分析,纳入409例机械通气患儿,在拔管前及拔管后5分钟和60分钟进行食管测压和呼吸感应体积描记测量。34例(8.3%)在拔管后48小时内再插管。再插管危险因素包括拔管前气道闭塞时最大气道压(aPiMax)较低、通气时间较长、拔管后上气道梗阻、拔管后呼吸用力高(压力速率乘积、压力时间乘积、张力时间指数)及拔管后相位角高。近35%患儿拔管时呼吸肌力量减弱(aPiMax≤30 cmH₂O),其再插管率 nearly 三倍于力量保留者(14% vs 5.5%,p=0.006)。
要点
- 拔管时aPiMax≤30 cmH₂O的患儿再插管率14%,显著高于aPiMax>30 cmH₂O者的5.5%(p=0.006)。
- 低aPiMax患儿拔管后压力速率乘积>500时再插管率超过20%,而aPiMax保留者仅在压力速率乘积>1,000时再插管率超过20%。
- 拔管后出现上气道梗阻时,低aPiMax患儿再插管率47.4%,显著高于aPiMax保留者的15.4%(p=0.02)。
- 多变量再插管危险因素包括急性神经系统疾病、较低aPiMax、拔管后上气道梗阻、拔管前较高PEEP、拔管后较高压力速率乘积及较低身高。
- 该研究为前瞻性收集数据的二次分析,单中心三级PICU,409例机械通气患儿,48小时内再插管率8.3%。
适用人群与场景
- 三级PICU中409例机械通气患儿。
诊断标准与关键阈值
- 呼吸肌力量减弱定义为拔管时气道闭塞时最大气道压(aPiMax)≤30 cmH₂O,力量保留定义为aPiMax>30 cmH₂O。
- 拔管后呼吸用力高定义为压力速率乘积>500(低aPiMax患儿)或>1,000(aPiMax保留患儿)。
红旗征与不能漏的情况
- 拔管后出现上气道梗阻:低aPiMax患儿再插管率47.4%,aPiMax保留者15.4%(p=0.02)。
- 低aPiMax合并拔管后压力速率乘积>500时再插管率超过20%。
研究设计与关键结果
- 研究类型为前瞻性收集数据的二次分析,样本量409例机械通气患儿,34例(8.3%)在拔管后48小时内再插管。
- 再插管危险因素包括拔管前aPiMax较低、通气时间较长、拔管后上气道梗阻、拔管后呼吸用力高(压力速率乘积、压力时间乘积、张力时间指数)及拔管后相位角高。
- 近35%患儿拔管时aPiMax≤30 cmH₂O,其再插管率14%,aPiMax>30 cmH₂O者再插管率5.5%(p=0.006),低aPiMax患儿再插管可能性约为力量保留者的三倍。
- 低aPiMax患儿拔管后压力速率乘积>500时再插管率超过20%,而aPiMax保留者仅在压力速率乘积>1,000时再插管率超过20%。
- 拔管后上气道梗阻时,低aPiMax患儿再插管率47.4%,aPiMax保留者15.4%(p=0.02)。
- 多变量再插管危险因素包括急性神经系统疾病、较低aPiMax、拔管后上气道梗阻、拔管前较高PEEP、拔管后较高压力速率乘积及较低身高。
证据类型、等级与局限
- 证据类型:前瞻性收集数据的二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对机械通气患儿拔管前可测量aPiMax以评估呼吸肌力量,aPiMax≤30 cmH₂O提示再插管风险较高。
- 拔管后需关注上气道梗阻和呼吸用力(压力速率乘积),低aPiMax患儿压力速率乘积>500时再插管风险已超过20%。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: Respiratory muscle weakness frequently develops during mechanical ventilation, although in children there are limited data about its prevalence and whether it is associated with extubation outcomes. We sought to identify risk factors for pediatric extubation failure, with specific attention to respiratory muscle strength.
DESIGN: Secondary analysis of prospectively collected data.
SETTING: Tertiary care PICU.
PATIENTS: Four hundred nine mechanically ventilated children.
INTERVENTIONS: Respiratory measurements using esophageal manometry and respiratory inductance plethysmography were made preextubation during airway occlusion and on continuous positive airway pressure of 5 and pressure support of 10 above positive end-expiratory pressure 5 cm H2O, as well as 5 and 60 minutes postextubation.
MEASUREMENTS AND MAIN RESULTS: Thirty-four patients (8.3%) were reintubated within 48 hours of extubation. Reintubation risk factors included lower maximum airway pressure during airway occlusion (aPiMax) preextubation, longer length of ventilation, postextubation upper airway obstruction, high respiratory effort postextubation (pressure rate product, pressure time product, tension time index), and high postextubation phase angle. Nearly 35% of children had diminished respiratory muscle strength (aPiMax ≤ 30 cm H2O) at the time of extubation, and were nearly three times more likely to be reintubated than those with preserved strength (aPiMax > 30 cm H2O; 14% vs 5.5%; p = 0.006). Reintubation rates exceeded 20% when children with low aPiMax had moderately elevated effort after extubation (pressure rate product > 500), whereas children with preserved aPiMax had reintubation rates greater than 20% only when postextubation effort was very high (pressure rate product > 1,000). When children developed postextubation upper airway obstruction, reintubation rates were 47.4% for those with low aPiMax compared to 15.4% for those with preserved aPiMax (p = 0.02). Multivariable risk factors for reintubation included acute neurologic disease, lower aPiMax, postextubation upper airway obstruction, higher preextubation positive end-expiratory pressure, higher postextubation pressure rate product, and lower height.
CONCLUSIONS: Neuromuscular weakness at the time of extubation was common in children and was independently associated with reintubation, particularly when postextubation effort was high.
参考来源
- Khemani RG, Sekayan T, Hotz J, et al. Risk Factors for Pediatric Extubation Failure: The Importance of Respiratory Muscle Strength. Crit Care Med. 2017. PMID: 28437378. doi:10.1097/CCM.0000000000002433
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。